Manufacturing

Impurities and batch-to-batch variability present the biggest challenges.

Limitations in production platforms have impeded continuous manufacturing for advanced therapies.

Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.

The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.

The Thermo Fisher Scientific Nicolet Summit X FTIR Spectrometer is a high-performance system designed for flexibility, ease of use, and high productivity.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Decreasing vein to vein time saves lives.

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.

Webinar Date/Time: Tue, Apr 25, 2023 11:00 AM EDT

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Adam C. Fisher, PhD, director of Science Staff and Immediate Office/Office of Pharmaceutical Quality at the Center for Drug Evaluation and Research/FDA, discusses point of care and patient manufacturing with Pharmaceutical Technology editor Jill Murphy.

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT

Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Manual aseptic operations make quality practices necessary in the manufacturing of compounded drugs.

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Webinar Date/Time: Tuesday, April 4th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST